Zinc sulfate 220mg capsules

Land: Verenigd Koninkrijk

Taal: Engels

Bron: MHRA (Medicines & Healthcare Products Regulatory Agency)

Koop het nu

Download Bijsluiter (PIL)
21-04-2020
Download Productkenmerken (SPC)
01-09-2017

Werkstoffen:

Zinc sulfate

Beschikbaar vanaf:

Waymade Healthcare Plc

ATC-code:

A12CB01

INN (Algemene Internationale Benaming):

Zinc sulfate

Dosering:

220mg

farmaceutische vorm:

Oral capsule

klasse:

No Controlled Drug Status

Prescription-type:

Valid as a prescribable product

Product samenvatting:

BNF: 09050401

Productkenmerken

                                SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Zinc Sulfate 220 mg Capsules.
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each capsule contains 220 mg Zinc Sulfate BP.
Excipients with known effect:
Lactose,
Brilliant black BN (E151)
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Hard capsule.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For the treatment of zinc deficiency which can occur in individuals on
an inadequate
diet, in malabsorption with increased tissue loss due to trauma,
burns, and protein-
losing conditions and during intravenous feeding.
Zinc Sulfate Capsules is indicated in adults, elderly and children
over 12 years.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
One capsule to be taken three times a day an hour before food or two
hours after
meals.
_ _
_Paediatric population _
The safety and efficacy of Zinc Sulfate Capsules in children under the
age of 12 years
have not yet been established. Currently available data are described
in section 5.1
and 5.2 but no recommendation on a posology can be made.
Method of administration
Oral use.
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients
listed in section
6.1.
Copper deficiency (see section 4.5).
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Therapy should continue until clinical improvement occurs and be
replaced by dietary
measures unless there is severe malabsorption, metabolic disease or
continuing zinc
loss.
Zinc capsules should be taken two hours before eating fibre containing
foods and
should not be taken within two hours of iron, copper or phosphorous
supplements.
Zinc levels may accumulate in acute renal failure.
Patients with rare hereditary problems of galactose intolerance, the
Lapp lactase
deficiency or glucose-galactose malabsorption should not take this
medicine.
4.5
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
_Copper:_
Large doses of zinc inhibit the absorption of copper in the intestine
(see section 4.3).
_ _
_Te
                                
                                Lees het volledige document
                                
                            

Zoekwaarschuwingen met betrekking tot dit product

Bekijk de geschiedenis van documenten